Primary hyperaldosteronism: Effect of adrenal vein sampling on surgical outcome

Archives of Surgery

Volumn 141, Issue 5, 2006, Pages 497-503

  Nwariaku, Fiemu E ^a,b   Miller, Barbra S ^a   Auchus, Richard ^a   Holt, Shelby ^a   Watumull, Lori ^a   Dolmatch, Bart ^a   Nesbitt, Shawna ^a   Vongpatanasin, Wanpen ^a   Victor, Ronald ^a   Wians, Frank ^a   Livingston, Edward ^a   Snyder III, William H ^a   Richards, Melanie ^c   Grant, Clive S ^c   Duh, Quan Yang ^c   Snyder, Samuel ^c   Sturgeon, Cord ^c   Biehl, Thomas ^c  

^a UNIVERSITY OF TEXAS AT DALLAS   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

EPLERENONE; SPIRONOLACTONE;

ADRENAL GLAND EXAMINATION; ADRENAL PHLEBOGRAPHY; ADRENALECTOMY; ADULT; ALDOSTERONE PRODUCING ADENOMA; ARTICLE; BILATERAL HYPERPLASIA; BIOCHEMISTRY; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DEMOGRAPHY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPOKALEMIA; INTERMETHOD COMPARISON; LAPAROSCOPY; MALE; PLASMA RENIN ACTIVITY; PRIMARY HYPERALDOSTERONISM; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SAMPLING; TREATMENT OUTCOME;

ADRENAL GLANDS; ADRENALECTOMY; ALDOSTERONE; CATHETERIZATION, PERIPHERAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERALDOSTERONISM; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PREOPERATIVE CARE; RETROSPECTIVE STUDIES; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME; VEINS;

EID: 33646591553     PISSN: 00040010     EISSN: 15383644     Source Type: Journal    
DOI: 10.1001/archsurg.141.5.497     Document Type: Article

References (33)

1. Loh KC, Koay ES, Khaw MC, Emmanuel SC, Young WF Jr. Prevalence of primary aldosteronism among Asian hypertensive patients in Singapore. J Clin Endocrinol Metab. 2000;85:2854-2859.
2. Rossi E, Regolisti G, Negro A, Sani C, Davoli S, Perazzoli F. High prevalence of primary aldosteronism using postcaptopril plasma aldosterone to renin ratio as a screening test among Italian hypertensives. Am J Hypertens. 2002;15:896-902.
3. Fardella CE, Mosso L, Gomez-Sanchez C, et al. Primary hyperaldosteronism in essential hypertensives: prevalence, biochemical profile, and molecular biology. J Clin Endocrinol Metab. 2000;85:1863-1867.
4. Young WF Jr. Minireview: primary aldosteronism-changing concepts in diagnosis and treatment. Endocrinology. 2003;144:2208-2213.
5. White EA, Schambelan M, Rost CR, Biglieri EG, Moss AA, Korobkin M. Use of computed tomography in diagnosing the cause of primary aldosteronism. N Engl J Med. 1980;303:1503-1507.
6. Nwariaku FE, Champine J, Kim LT, Burkey S, O'keefe G, Snyder WH III. Radiologic characterization of adrenal masses: the role of computed tomography-derived attenuation values. Surgery. 2001;130:1068-1071.
7. Korobkin M. CT characterization of adrenal masses: the time has come. Radiology. 2000;217:629-632.
8. Boland GW, Lee MJ, Gazelle GS, Halpern EF, McNicholas MM, Mueller PR. Characterization of adrenal masses using unenhanced CT: an analysis of the CT literature. AJR Am J Roentgenol. 1998;171:201-204.
9. Francis IR, Korobkin M. Incidentally discovered adrenal masses. Magn Reson Imaging Clin N Am. 1997;5:147-164.
10. Bastounis EA, Karayiannakis AJ, Anapliotou ML, Nakopoulou L, Makri GG, Papalambros EL. Incidentalomas of the adrenal gland: diagnostic and therapeutic implications. Am Surg. 1997;63:356-360.
11. Ganguly A. Primary aldosteronism. N Engl J Med. 1998;339:1828-1834.
12. Nomura K, Kusakabe K, Maki M, Ito Y, Aiba M, Demura H. Iodomethylnorcholesterol uptake in an aldosteronoma shown by dexamethasone-suppression scintigraphy: relationship to adenoma size and functional activity. J Clin Endocrinol Metab. 1990;71:825-830.
13. Rossi GP, Chiesura-Corona M, Tregnaghi A, et al. Imaging of aldosterone-secreting adenomas: a prospective comparison of computed tomography and magnetic resonance imaging in 27 patients with suspected primary aldosteronism. J Hum Hypertens. 1993;7:357-363.
14. Geisinger MA, Zelch MG, Bravo EL, Risius BF, O'Donovan PB, Borkowski GP. Primary hyperaldosteronism: comparison of CT, adrenal venography, and venous sampling. AJR Am J Roentgenol. 1983;141:299-302.
15. Young WF, Stanson AW, Thompson GB, Grant CS, Farley DR, van Heerden JA. Role for adrenal venous sampling in primary aldosteronism. Surgery. 2004;136:1227-1235.
16. Rossi GP, Sacchetto A, Chiesura-Corona M, et al. Identification of the etiology of primary aldosteronism with adrenal vein sampling in patients with equivocal computed tomography and magnetic resonance findings: results in 104 consecutive cases. J Clin Endocrinol Metab. 2001;86:1083-1090.
17. Magill SB, Raff H, Shaker JL, et al. Comparison of adrenal vein sampling and computed tomography in the differentiation of primary aldosteronism. J Clin Endocrinol Metab. 2001;86:1066-1071.
18. Doppman JL, Gill JR Jr, Miller DL, et al. Distinction between hyperaldosteronism due to bilateral hyperplasia and unilateral aldosteronoma: reliability of CT. Radiology. 1992;184:677-682.
19. Young WF Jr, Klee GG. Primary aldosteronism: diagnostic evaluation. Endocrinol Metab Clin North Am. 1988;17:367-395.
20. Young WF Jr, Stanson AW, Grant CS, Thompson GB, van Heerden JA. Primary aldosteronism: adrenal venous sampling. Surgery. 1996;120:913-919.
21. Doppman JL, Gill JR Jr. Hyperaldosteronism: sampling the adrenal veins. Radiology. 1996;198:309-312.
22. Rossi GP, Sacchetto A, Visentin P, et al. Changes in left ventricular anatomy and function in hypertension and primary aldosteronism. Hypertension. 1996;27:1039-1045.
23. Sawka AM, Young WF, Thompson GB, et al. Primary aldosteronism: factors associated with normalization of blood pressure after surgery. Ann Intern Med. 2001;135:258-261.
24. Celen O, O'Brien MJ, Melby JC, Beazley RM. Factors influencing outcome of surgery for primary aldosteronism. Arch Surg. 1996;131:646-650.
25. Rocha R, Martin-Berger CL, Yang P, Scherrer R, Delyani J, McMahon E. Selective aldosterone blockade prevents angiotensin II/salt-induced vascular inflammation in the rat heart. Endocrinology. 2002;143:4828-4836.
26. Rocha R, Rudolph AE, Frierdich GE, et al. Aldosterone induces a vascular inflammatory phenotype in the rat heart. Am J Physiol Heart Circ Physiol. 2002;283:H1802-H1810.
27. Rocha R, Funder JW. The pathophysiology of aldosterone in the cardiovascular system. Ann N Y Acad Sci. 2002;970:89-100.
28. Rocha R, Williams GH. Rationale for the use of aldosterone antagonists in congestive heart failure. Drugs. 2002;62:723-731.
29. Stier CT Jr, Chander PN, Rocha R. Aldosterone as a mediator in cardiovascular injury. Cardiol Rev. 2002;10:97-107.
30. Martinez DV, Rocha R, Matsumura M, et al. Cardiac damage prevention by eplerenone: comparison with low sodium diet or potassium loading. Hypertension. 2002;39:614-618.
31. Ghose RP, Hall PM, Bravo EL. Medical management of aldosterone-producing adenomas. Ann Intern Med. 1999;131:105-108.
32. Bravo EL. Medical management of primary hyperaldosteronism. Curr Hypertens Rep. 2001;3:406-409.
33. Sywak M, Pasieka JL. Long-term follow-up and cost benefit of adrenalectomy in patients with primary hyperaldosteronism. Br J Surg. 2002;89:1587-1593.